Literature DB >> 20060152

Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.

Mehsati Herawi1, Peter A Drew, Chin-Chen Pan, Jonathan I Epstein.   

Abstract

Although clear cell adenocarcinoma have been described focally mimicking nephrogenic adenoma, we have identified a subset of clear cell adenocarcinoma that diffusely resembles nephrogenic adenoma (nephrogenic adenoma-like clear cell adenocarcinoma). Twelve classic clear cell adenocarcinomas of the bladder and urethra and 7 nephrogenic adenoma-like clear cell adenocarcinomas were compared to 10 nephrogenic adenomas. Classic clear cell adenocarcinomas and nephrogenic adenoma-like clear cell adenocarcinomas comprised 4 men and 15 women. The following features were seen in classic clear cell adenocarcinomas: nephrogenic adenoma-like clear cell adenocarcinomas: predominantly solid pattern (7/12:0/7), marked nuclear pleomorphism (7/12:1/7), prominent nucleoli (5/12:1/7), clear cytoplasm in 50% or greater of tumor (7/12:0/7), and necrosis (8/12:3/7), although the necrosis in nephrogenic adenoma-like clear cell adenocarcinomas was often focal and intraluminal. Both patterns of clear cell adenocarcinomas showed prominent hobnail features, although more pronounced in nephrogenic adenoma-like clear cell adenocarcinomas. Muscularis propria invasion was seen in 5 of 9 classic clear cell adenocarcinomas and 6 of 6 nephrogenic adenoma-like clear cell adenocarcinomas, where evaluable. Classic clear cell adenocarcinoma was associated with urothelial carcinoma (n = 2) and endometriosis (n = 1). The Ki-67 rate in clear cell adenocarcinomas ranged from 10% to 80% compared with 0% to 5% in nephrogenic adenoma. The following antibodies were not helpful in distinguishing nephrogenic adenoma-like clear cell adenocarcinoma from nephrogenic adenoma: CD10, estrogen receptor, p63, high-molecular-weight cytokeratin, and alpha-methylacyl coenzyme-A racemase. PAX2 expression was more frequent in nephrogenic adenoma (89%) compared to both patterns of clear cell adenocarcinoma (29%-32%). The key features discriminating between nephrogenic adenoma-like clear cell adenocarcinoma and nephrogenic adenoma include occasional clear cells, more prominent pleomorphism especially hyperchromatic enlarged nuclei, and extensive muscular invasion. Presence of mitoses and a high rate of Ki-67 expression in lesions resembling nephrogenic adenoma require clinical correlation, close follow-up, and repeat biopsy with more extensive sampling. Copyright 2010 Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20060152     DOI: 10.1016/j.humpath.2009.10.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Authors:  Oluwole Fadare; Vinita Parkash; Katja Gwin; Krisztina Z Hanley; Elke A Jarboe; Sharon X Liang; Charles M Quick; Wenxin Zheng; Kojo R Rawish; Jonathan L Hecht; Mohamed M Desouki
Journal:  Hum Pathol       Date:  2013-10-10       Impact factor: 3.466

2.  Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Authors:  Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J Lonigro; Javed Siddiqui; Alon Weizer; Cheryl Lee; Xuhong Cao; Yi-Mi Wu; Dan R Robinson; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Am J Pathol       Date:  2014-01-03       Impact factor: 4.307

3.  Molecular profiling of clear cell adenocarcinoma of the urinary tract.

Authors:  Chieh-Yu Lin; Atif Saleem; Henning Stehr; James L Zehnder; Benjamin A Pinsky; Christian A Kunder
Journal:  Virchows Arch       Date:  2019-08-02       Impact factor: 4.064

4.  Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.

Authors:  José I López; Marco Schiavo-Lena; Alexandra Corominas-Cishek; Adriana Yagüe; Kevin Bauleth; Rosa Guarch; Ondrej Hes; Regina Tardanico
Journal:  Virchows Arch       Date:  2013-10-19       Impact factor: 4.064

5.  Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems.

Authors:  Borislav A Alexiev; Fabio Tavora
Journal:  Virchows Arch       Date:  2013-01-11       Impact factor: 4.064

6.  A case of clear cell adenocarcinoma arising from the urethral diverticulum: Utility of urinary cytology and immunohistochemistry.

Authors:  Shin-Ichi Nakatsuka; Isao Taguchi; Tadasuke Nagatomo; Michiaki Yamane; Kenji Sugio; Ryuichi Yoshino; Kazuko Oku; Teruaki Nagano; Hayato Kimura; Kazuya Nakajo; Gaku Kawabata
Journal:  Cytojournal       Date:  2012-04-30       Impact factor: 2.091

7.  Clear cell adenocarcinoma of the renal pelvis in a male patient.

Authors:  Sarawut Kongkarnka; Pruit Kitirattakarn; Hironori Katayama; Surapan Khunamornpong
Journal:  Case Rep Pathol       Date:  2013-12-23

Review 8.  Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.

Authors:  Virginia M Knez; Willis Barrow; M Scott Lucia; Shandra Wilson; Francisco G La Rosa
Journal:  J Med Case Rep       Date:  2014-08-14

Review 9.  Clear cell adenocarcinoma of the urethra: review of the literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int J Surg Oncol       Date:  2015-01-20

Review 10.  Nephrogenic Adenoma of the Urinary Bladder: A Review of the Literature.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Int Sch Res Notices       Date:  2015-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.